What is Epic Pharma?
Epic Pharma operates as a premier FDA-approved generic pharmaceutical entity, distinguished by its robust development, manufacturing, and distribution infrastructure. The company maintains a diverse product portfolio that encompasses essential therapeutic areas such as cardiovascular health, respiratory care, and anti-infectives. Beyond its proprietary product line, Epic Pharma provides specialized contract manufacturing services, adhering to stringent regulatory standards and rigorous quality control protocols. This dual-model approach allows the firm to maintain a competitive edge while serving as a critical partner in the pharmaceutical supply chain, effectively balancing cost-efficiency with clinical safety and compliance.
How much funding has Epic Pharma raised?
Epic Pharma has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Epic Pharma
PPP
Public-Private Partnership
What's next for Epic Pharma?
With the recent influx of capital, Epic Pharma is well-positioned to accelerate its enterprise-level growth strategy. The firm is expected to prioritize the optimization of its manufacturing facilities to meet increasing demand for generic alternatives, while simultaneously exploring advancements in drug delivery systems. By reinvesting in its core competencies and expanding its contract manufacturing capacity, Epic Pharma is poised to capture additional market share. Future initiatives will likely focus on navigating complex regulatory environments and scaling production to support long-term sustainability in the global healthcare market, ultimately reinforcing its reputation as a reliable provider of essential medications.
See full Epic Pharma company page
